DENTSPLY SIRONA ( (XRAY) ) has released its Q4 earnings. Here is a breakdown of the information DENTSPLY SIRONA presented to its investors.
Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, offering a comprehensive range of dental and oral health solutions. The company, headquartered in Charlotte, North Carolina, is listed on Nasdaq under the symbol XRAY.
Dentsply Sirona reported a challenging year in 2024, with net sales decreasing by 4.3% to $3,793 million and a GAAP net loss of $910 million. The fourth quarter saw a significant drop in sales by 10.6%, contributing to a quarterly net loss of $430 million. Despite these setbacks, the company highlighted progress in its transformational agenda aimed at long-term success.
Key financial metrics revealed a decrease in adjusted earnings per share to $1.67 for the full year, down from $1.83 in 2023. The company faced substantial non-cash charges for goodwill and intangible asset impairments, totaling $870 million for the year. Segment performance varied, with Wellspect Healthcare showing growth, while the Orthodontic and Implant Solutions segment experienced declines.
Looking ahead to 2025, Dentsply Sirona anticipates net sales between $3.50 billion and $3.60 billion, with organic sales expected to decline by 2% to 4%. The company projects adjusted earnings per share to range from $1.80 to $2.00, driven by its ongoing transformational initiatives aimed at expanding EBITDA margins and enhancing customer experience.
Dentsply Sirona remains focused on leveraging its differentiated portfolio and innovation pipeline to navigate the competitive landscape and create value for stakeholders, despite the persistent macroeconomic pressures expected in the coming year.